SEC Form 4 · accession 0001765581-19-000041
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew P. Young
Officer — EVP & CFO
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 5, 2019 | F | 1,267 | $135.82 | D | 38,700 | D | |
| Ordinary Shares | Mar 5, 2019 | F | 1,348 | $135.82 | D | 37,352 | D | |
| Ordinary Shares | Mar 6, 2019 | S | 1,152 | $135.41 | D | 36,200 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.